A citation-based method for searching scientific literature

Hermela Shimelis, Holly LaDuca, Chunling Hu, Steven N Hart, Jie Na, Abigail Thomas, Margaret Akinhanmi, Raymond M Moore, Hiltrud Brauch, Angela Cox, Diana M Eccles, Amanda Ewart-Toland, Peter A Fasching, Florentia Fostira, Judy Garber, Andrew K Godwin, Irene Konstantopoulou, Heli Nevanlinna, Priyanka Sharma, Drakoulis Yannoukakos, Song Yao, Bing-Jian Feng, Brigette Tippin Davis, Jenna Lilyquist, Tina Pesaran, David E Goldgar, Eric C Polley, Jill S Dolinsky, Fergus J Couch. J Natl Cancer Inst 2018
Times Cited: 145



Alfons Meindl, Heide Hellebrand, Constanze Wiek, Verena Erven, Barbara Wappenschmidt, Dieter Niederacher, Marcel Freund, Peter Lichtner, Linda Hartmann, Heiner Schaal, Juliane Ramser, Ellen Honisch, Christian Kubisch, Hans E Wichmann, Karin Kast, Helmut Deissler, Christoph Engel, Bertram Müller-Myhsok, Kornelia Neveling, Marion Kiechle, Christopher G Mathew, Detlev Schindler, Rita K Schmutzler, Helmut Hanenberg. Nat Genet 2010
Times Cited: 473




List of shared articles



Times cited

Integration of tumour sequencing and case-control data to assess pathogenicity of RAD51C missense variants in familial breast cancer.
Belle W X Lim, Na Li, Simone M Rowley, Ella R Thompson, Simone McInerny, Magnus Zethoven, Rodney J Scott, Lisa Devereux, Erica K Sloan, Paul A James,[...]. NPJ Breast Cancer 2022
0

Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness.
Farzaneh Darbeheshti, Sepideh Kadkhoda, Mahsa Keshavarz-Fathi, Sepideh Razi, Afshin Bahramy, Yaser Mansoori, Nima Rezaei. BMC Cancer 2022
0

Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination.
Jeremy Setton, Pier Selenica, Semanti Mukherjee, Rachna Shah, Isabella Pecorari, Biko McMillan, Isaac X Pei, Yelena Kemel, Ozge Ceyhan-Birsoy, Margaret Sheehan,[...]. NPJ Breast Cancer 2021
0

A dominant RAD51C pathogenic splicing variant predisposes to breast and ovarian cancer in the Newfoundland population due to founder effect.
Lesa M Dawson, Kerri N Smith, Salem Werdyani, Robyn Ndikumana, Cindy Penney, Louisa L Wiede, Kendra L Smith, Justin A Pater, Andrée MacMillan, Jane Green,[...]. Mol Genet Genomic Med 2020
2

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D.
Xin Yang, Honglin Song, Goska Leslie, Christoph Engel, Eric Hahnen, Bernd Auber, Judit Horváth, Karin Kast, Dieter Niederacher, Clare Turnbull,[...]. J Natl Cancer Inst 2020
50

Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.
Julie R Palmer, Eric C Polley, Chunling Hu, Esther M John, Christopher Haiman, Steven N Hart, Mia Gaudet, Tuya Pal, Hoda Anton-Culver, Amy Trentham-Dietz,[...]. J Natl Cancer Inst 2020
28

Association of RAD51C germline mutations with breast cancer among Bahamians.
Maryam Bagherzadeh, Agata Szymiczek, Talia Donenberg, Raleigh Butler, Judith Hurley, Steven A Narod, Mohammad R Akbari. Breast Cancer Res Treat 2020
3

Regulation and pharmacological targeting of RAD51 in cancer.
McKenzie K Grundy, Ronald J Buckanovich, Kara A Bernstein. NAR Cancer 2020
19